VIA THERAPEUTICS, LLC
US UEI YHRZATLXKL46 · SME
15public awards
$12.6Mtotal public funding
2026-07-10latest award
State aid awards (15)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-07-10 | $2.8M | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-07-07 | $314k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-07-07 | $314k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2025-09-18 | $314k | Grant | Combined Amikacin and Azithromycin in an Inhaled Formulation for the T | Department of Health and Human Services |
| 2025-09-11 | $314k | Grant | Microneedle-based mRNA Flu Vaccine for Transcutaneous Immunization | Department of Health and Human Services |
| 2024-08-01 | $300k | Grant | Inhalable dry powders of mycobacteriophages for tuberculosis therapy | Department of Health and Human Services |
| 2023-07-03 | $1.9M | Grant | Development of a shelf-stable universal mucosal HA-vaccine for the pre | Department of Health and Human Services |
| 2023-01-01 | $1.5M | Grant | Phase II: Development of Low-Cost, Shelf-Stable Treatment for Tubercul | Department of Health and Human Services |
| 2021-07-12 | $252k | Grant | Discovery of epidermal/dermal targeting formulations for cutaneous squ | Department of Health and Human Services |
| 2021-03-01 | $256k | Grant | Development of synergistic clofazimine-amikacin inhalable powders for | Department of Health and Human Services |
| 2021-01-01 | $300k | Grant | DEVELOPMENT OF LOW-COST, SHELF-STABLE, PATIENT- ADAPTABLE CLOFAZIMINE | Department of Health and Human Services |
| 2020-08-01 | $264k | Grant | Enabling the repurposing of niclosamide for castrate-resistant prostat | Department of Health and Human Services |
| 2020-01-01 | $3.0M | Grant | INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, | Department of Health and Human Services |
| 2018-09-01 | $225k | Grant | Preclinical evaluation of co-delivery of TNF-alpha siRNA and a glucoco | Department of Health and Human Services |
| 2018-01-01 | $600k | Grant | Inhaled Delivery of Clofazimine - A High Efficiency, Flow Independent, | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →